21st Sep 2023 21:14
4basebio PLC - Heidelberg, Germany-based life sciences company - Pretax loss in the six months to June 30 widens to GBP3.9 million from GBP2.7 million a year prior. Revenue grows 57% to GBP238,000 from GBP152,000. Research and non-captialised development expenses however increase 56% to GBP1.6 million from GBP1.0 million. Administrative expenses increase 23% to GBP1.6 million from GBP1.3 million, as sales and marketing expenses increase to GBP248,000 from GBP97,000. Looking ahead, expects to secure new clients in the second half of 2023.
Current stock price: 599.00 pence, closed 1.8% lower on Thursday in London
12-month change: up 4.2%
By Tom Budszus, Alliance News reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.